Development and characterization of a doxorubicin-resistant triple-negative breast cancer spheroid model for drug screening purposes.
Triple negative breast cancer (TNBC) is the most fatal subtype of breast cancer. Cytotoxic chemotherapy and immune therapy remain the only available therapeutic strategies for treatment, but unfortunately, patients frequently develop drug-resistance. Drug resistance towards chemotherapeutic agents is a major obstacle f...